3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
8
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
17
Carcinoma, Ovarian Epithelial
12
Breast Neoplasms
8
Fallopian Tube Neoplasms
7
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Colorectal Neoplasms
4
Small Cell Lung Carcinoma
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Testicular Neoplasms
2
Testicular Germ Cell Tumor
2
Squamous Cell Carcinoma of Head and Neck
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Neoplasms
2
Melanoma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hodgkin Disease
2
Colonic Neoplasms
2
Interventions
Trastuzumab
4
liposomal doxorubicin
2
Interleukin-12 Subunit p35
2
Interleukin-12
2
Early Intervention, Educational
2
Docetaxel
2
veliparib
1
tipifarnib
1
temsirolimus
1
sargramostim
1
ixabepilone
1
entinostat
1
cediranib
1
Watchful Waiting
1
Vorinostat
1
Vinorelbine
1
Therapeutics
1
Taxes
1
TIC10 compound
1
Standard of Care
1
Sirolimus
1
Radiotherapy
1
Pyridoxine
1
Psychiatric Rehabilitation
1
Propranolol
1
Practice Guidelines as Topic
1
Physical Therapy Modalities
1
Pemetrexed
1
Paclitaxel
1
Mifepristone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms, Male
×
sargramostim
×
Gynecologic
×
Clear all
NCT02019524
2020-03-18
J65
San Antonio Military Medical Center
Phase 1
Completed
39 enrolled